OleanderUpdate on Phase I trial of PBI-05204: ASCO annual meeting poster presentation with discussion. Posted on May 2009June 2022 by Carlos Torres 06 May READ MORE Phoenix Biotechnology executes a Sponsored Research Agreement with Duke University for in vitro research in neurological disorders using PBI-05204 and certain discrete fractions of the whole extract. Phoenix Biotechnology executes a third amendment to its Sponsored Research Agreement with M. D. Anderson Cancer Center.
